← Eichor
Study identifier: NCT07166991 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Anesthesia sTrategy foR Organ Procurement In braiN dEath

Condition: Brain-dead Organ Donors  ·  Sponsor: University Hospital, Grenoble

PhasePhase 3
Planned participants270
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The optimal anesthetic strategy during organ procurement in brain-dead donors remains unknown. The administration of anesthetic drugs in this setting aims to preserve hemodynamic stability in the face of reflex responses mediated by preserved spinal activity. Volatile anesthetics may blunt these reflexes, but their potential benefits in this context have never been investigated. This randomized trial evaluates the effects of volatile anesthesia (sevoflurane), opioid administration (sufentanil), or no anesthetic drugs on intraoperative hemodynamic stability during organ procurement in brain-dead donors. The primary outcome is the proportion of operative time within a predefined arterial blood pressure range.

This description comes directly from the study's public registry record.

Talk to the study team

Benoit CHAMPIGNEULLE, MD, PhD  ·  +33476766879  ·  BChampigneulle@chu-grenoble.fr

Anaïs ADOLLE  ·  +33476766879  ·  aadolle@chu-grenoble.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU Grenoble AlpesGrenoble, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07166991